Quadrant Capital Group LLC cut its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 3.8% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,687 shares of the company’s stock after selling 107 shares during the period. Quadrant Capital Group LLC’s holdings in Clorox were worth $427,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. Bogart Wealth LLC grew its stake in shares of Clorox by 105.6% during the second quarter. Bogart Wealth LLC now owns 185 shares of the company’s stock valued at $29,000 after acquiring an additional 95 shares in the last quarter. Strategic Investment Solutions Inc. IL acquired a new position in Clorox in the first quarter worth about $31,000. Ten Capital Wealth Advisors LLC grew its stake in Clorox by 429.7% in the first quarter. Ten Capital Wealth Advisors LLC now owns 196 shares of the company’s stock worth $31,000 after purchasing an additional 159 shares in the last quarter. Barrett & Company Inc. grew its stake in Clorox by 540.5% in the second quarter. Barrett & Company Inc. now owns 237 shares of the company’s stock worth $38,000 after purchasing an additional 200 shares in the last quarter. Finally, Compass Wealth Management LLC acquired a new position in Clorox in the fourth quarter worth about $39,000. 77.98% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
CLX has been the subject of a number of research reports. UBS Group upgraded Clorox from a “sell” rating to a “neutral” rating and lifted their price target for the stock from $124.00 to $132.00 in a research note on Monday, November 6th. DA Davidson lifted their target price on Clorox from $152.00 to $162.00 and gave the company a “buy” rating in a research note on Friday. Atlantic Securities upgraded Clorox from an “underweight” rating to a “neutral” rating in a research note on Thursday, August 3rd. Barclays decreased their target price on Clorox from $127.00 to $116.00 in a research note on Thursday, October 5th. Finally, Jefferies Financial Group assumed coverage on Clorox in a research note on Monday, November 13th. They issued an “underperform” rating and a $117.00 target price for the company. Six investment analysts have rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, Clorox has a consensus rating of “Hold” and a consensus target price of $138.13.
Clorox Price Performance
Shares of NYSE:CLX opened at $139.17 on Friday. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $178.21. The stock has a market cap of $17.26 billion, a price-to-earnings ratio of 204.65, a PEG ratio of 3.02 and a beta of 0.35. The stock’s 50 day moving average price is $130.12 and its 200 day moving average price is $148.67. The company has a debt-to-equity ratio of 18.92, a current ratio of 0.86 and a quick ratio of 0.54.
Clorox (NYSE:CLX – Get Free Report) last announced its earnings results on Wednesday, November 1st. The company reported $0.49 EPS for the quarter, topping the consensus estimate of ($0.20) by $0.69. Clorox had a return on equity of 195.76% and a net margin of 1.22%. The firm had revenue of $1.39 billion for the quarter, compared to analysts’ expectations of $1.31 billion. During the same quarter in the previous year, the company earned $0.93 earnings per share. The firm’s quarterly revenue was down 20.3% compared to the same quarter last year. Equities research analysts anticipate that The Clorox Company will post 4.51 earnings per share for the current fiscal year.
Clorox Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be issued a dividend of $1.20 per share. The ex-dividend date is Tuesday, January 23rd. This represents a $4.80 annualized dividend and a yield of 3.45%. Clorox’s payout ratio is 705.88%.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
- Five stocks we like better than Clorox
- How to Invest in Pharmaceutical Companies
- MarketBeat Week in Review – 11/13 – 11/17
- What Is Dividend Yield and How Do You Calculate It?
- 3 large caps with red hot RSIs with upside
- Want to Profit on the Downtrend? Downtrends, Explained.
- Johnson Controls International: Nothing but upside for investors
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.